TrialEuropean heart journal2024

Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial.

Marie-A Chaix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.